
New cellular therapy trials for brain tumors
Phase I trials target aggressive tumors in children
Phase I trials target aggressive tumors in children
Avapritinib, an FDA-approved drug used to treat other types of cancer, also decreases aggressive gliomas in animal models and in an initial cohort of patients with high-grade glioma
Atypical Teratoid Rhabdoid Tumors are a fast-growing cancer of the brain and spine
Researchers found that these tumors’ metabolism differs from adult brain tumors, a key to understanding treatment resistance in this aggressive form of cancer
Experts discuss the latest brain cancer research.
Featuring Suresh Magge, M.D. , pediatric neurosurgeon at the University of Michigan Health C.S. Mott Children’s Hospital.